178 related articles for article (PubMed ID: 32193478)
1. The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index.
Park HE; Lee H; Choi SY; Kim HS; Chung GE
Sci Rep; 2020 Mar; 10(1):5023. PubMed ID: 32193478
[TBL] [Abstract][Full Text] [Related]
2. Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Kang MK; Park JG; Kim MC
Yonsei Med J; 2020 Oct; 61(10):860-867. PubMed ID: 32975060
[TBL] [Abstract][Full Text] [Related]
3. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
Käräjämäki AJ; Hukkanen J; Ukkola O
Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease.
Singh A; Gosai F; Siddiqui MT; Gupta M; Lopez R; Lawitz E; Poordad F; Carey W; McCullough A; Alkhouri N
J Clin Gastroenterol; 2020; 54(10):891-897. PubMed ID: 32168133
[TBL] [Abstract][Full Text] [Related]
5. Liver fibrosis scores and atrial fibrillation incidence in heart failure with preserved ejection fraction.
Liu X; Chen W; Shao W; Jiang Y; Cao Z; He W; Wu M; Chen Z; Ma J; Chen Y; Yu P; Zhang Y; Wang J
ESC Heart Fail; 2022 Dec; 9(6):3985-3994. PubMed ID: 35996808
[TBL] [Abstract][Full Text] [Related]
6. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
[TBL] [Abstract][Full Text] [Related]
7. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
Käräjämäki AJ; Pätsi OP; Savolainen M; Kesäniemi YA; Huikuri H; Ukkola O
PLoS One; 2015; 10(11):e0142937. PubMed ID: 26571029
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation.
Cai X; Zheng S; Liu Y; Zhang Y; Lu J; Huang Y
Liver Int; 2020 Jul; 40(7):1594-1600. PubMed ID: 32279432
[TBL] [Abstract][Full Text] [Related]
9. Liver Fibrosis-4 index indicates atrial fibrillation in acute ischemic stroke.
Fandler-Höfler S; Kneihsl M; Stauber RE; Bisping E; Mangge H; Wünsch G; Haidegger M; Fabisch L; Hatab I; Fickert P; Werring D; Enzinger C; Gattringer T
Eur J Neurol; 2022 Aug; 29(8):2283-2288. PubMed ID: 35485970
[TBL] [Abstract][Full Text] [Related]
10. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease.
Lee J; Kim HS; Cho YK; Kim EH; Lee MJ; Bae IY; Jung CH; Park JY; Kim HK; Lee WJ
Sci Rep; 2020 Oct; 10(1):18323. PubMed ID: 33110139
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study.
Lee SR; Han KD; Choi EK; Oh S; Lip GYH
Sci Rep; 2021 Feb; 11(1):3737. PubMed ID: 33580177
[TBL] [Abstract][Full Text] [Related]
12. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease (NAFLD) fibrosis score predicts 6.6-year overall mortality of Chinese patients with NAFLD.
Xun YH; Guo JC; Lou GQ; Jiang YM; Zhuang ZJ; Zhu MF; Luo Y; Ma XJ; Liu J; Bian DX; Shi JP
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):643-9. PubMed ID: 24837195
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
Castellana M; Donghia R; Guerra V; Procino F; Castellana F; Zupo R; Lampignano L; Sardone R; De Pergola G; Romanelli F; Trimboli P; Giannelli G
Am J Gastroenterol; 2021 Sep; 116(9):1833-1841. PubMed ID: 34160377
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease.
Alkayyali T; Qutranji L; Kaya E; Bakir A; Yilmaz Y
Acta Diabetol; 2020 May; 57(5):613-618. PubMed ID: 31897769
[TBL] [Abstract][Full Text] [Related]
17. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
18. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
Roh JH; Lee JH; Lee H; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Liver Int; 2020 Feb; 40(2):338-346. PubMed ID: 31479572
[TBL] [Abstract][Full Text] [Related]
19. Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease.
Bertot LC; Jeffrey GP; de Boer B; MacQuillan G; Garas G; Chin J; Huang Y; Adams LA
Liver Int; 2018 Oct; 38(10):1793-1802. PubMed ID: 29575516
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).
Önnerhag K; Hartman H; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2019 Mar; 54(3):328-334. PubMed ID: 30907181
[No Abstract] [Full Text] [Related]
[Next] [New Search]